BerandaAJANTPHARM • NSE
add
Ajanta Pharma Ltd
Tutup sebelumnya
₹3.026,80
Rentang hari
₹2.911,05 - ₹3.042,70
Rentang tahun
₹1.850,25 - ₹3.485,00
Kapitalisasi pasar
365,29Â M INR
Volume Rata-Rata
88,27Â rb
Rasio P/E
42,05
Hasil dividen
1,85%
Bursa utama
NSE
Berita pasar
Keuangan
Laporan Pendapatan
Pendapatan
Laba bersih
(INR) | Sep 2024info | Perubahan Y/Y |
---|---|---|
Pendapatan | 11,87Â M | 15,38% |
Biaya operasional | 6,23Â M | 20,79% |
Laba bersih | 2,16Â M | 10,84% |
Margin laba bersih | 18,24 | -3,95% |
Penghasilan per saham | 17,26 | 11,35% |
EBITDA | 3,37Â M | 15,91% |
Tarif pajak efektif | 25,41% | — |
Neraca
Total aset
Total liabilitas
(INR) | Sep 2024info | Perubahan Y/Y |
---|---|---|
Investasi tunai jangka pdk | 7,42Â M | 56,00% |
Total aset | 47,90Â M | 8,06% |
Total liabilitas | 11,14Â M | 17,05% |
Total ekuitas | 36,77 M | — |
Saham yang beredar | 125,35 jt | — |
Harga terhadap nilai buku | 10,32 | — |
Tingkat pengembalian aset | — | — |
Tingkat pengembalian modal | 20,67% | — |
Arus Kas
Perubahan kas bersih
(INR) | Sep 2024info | Perubahan Y/Y |
---|---|---|
Laba bersih | 2,16Â M | 10,84% |
Kas dari operasi | — | — |
Kas dari investasi | — | — |
Kas dari pembiayaan | — | — |
Perubahan kas bersih | — | — |
Arus kas bebas | — | — |
Tentang
Ajanta Pharma Limited, also known by the acronym APL, is a multinational company based in India engaged in development, manufacturing, and marketing of pharmaceutical formulations. It has a presence in India, the United States, and about 30 other countries in Africa, South East Asia, West Asia, and CIS. It was established in 1973. Wikipedia
Didirikan
1973
Situs
Karyawan
8.073